RESUMEN
It has long been appreciated that insulin action is closely tied to circadian rhythms. However, the mechanisms that dictate diurnal insulin sensitivity in metabolic tissues are not well understood. Retinol-binding protein 4 (RBP4) has been implicated as a driver of insulin resistance in rodents and humans, and it has become an attractive drug target in type II diabetes. RBP4 is synthesized primarily in the liver where it binds retinol and transports it to tissues throughout the body. The retinol-RBP4 complex (holo-RBP) can be recognized by a cell-surface receptor known as stimulated by retinoic acid 6 (STRA6), which transports retinol into cells. Coupled to retinol transport, holo-RBP can activate STRA6-driven Janus kinase (JAK) signaling and downstream induction of signal transducer and activator of transcription (STAT) target genes. STRA6 signaling in white adipose tissue has been shown to inhibit insulin receptor responses. Here, we examined diurnal rhythmicity of the RBP4/STRA6 signaling axis and investigated whether STRA6 is necessary for diurnal variations in insulin sensitivity. We show that adipose tissue STRA6 undergoes circadian patterning driven in part by the nuclear transcription factor REV-ERBα. Furthermore, STRA6 is necessary for diurnal rhythmicity of insulin action and JAK/STAT signaling in adipose tissue. These findings establish that holo-RBP and its receptor STRA6 are potent regulators of diurnal insulin responses and suggest that the holo-RBP/STRA6 signaling axis may represent a novel therapeutic target in type II diabetes.
Asunto(s)
Ritmo Circadiano , Insulina/metabolismo , Proteínas de la Membrana/metabolismo , Tejido Adiposo Blanco/metabolismo , Animales , Diabetes Mellitus Tipo 2/metabolismo , Proteínas de la Membrana/deficiencia , Ratones , Ratones Noqueados , Transducción de SeñalRESUMEN
The transmembrane protein, STRA6, functions as a vitamin A transporter and a cytokine receptor when activated by vitamin A-bound serum retinol binding protein 4 (RBP4). STRA6 activation transduces a JAK2-STAT3 signaling cascade and promotes tumorigenesis in a xenograft mouse model of colon cancer. We show here that RBP4 and STRA6 expression is associated with poor oncologic prognosis. Downregulating STRA6 or RBP4 in colon cancer cells decreased the fraction of cancer stem cells and their sphere and tumor initiation frequency. Furthermore, we show that high-fat diet (HFD) increases LGR5 expression and promotes tumor growth in a xenograft model independent of obesity. HFD increased STRA6 levels, and downregulation of STRA6 delays and impairs tumor initiation, tumor growth, and expression of stemness markers. Together, these data demonstrate a key role of STRA6 and RBP4 in the maintenance of colon cancer self-renewal and that this pathway is an important link through which consumption of HFD contributes to colon carcinogenesis.
Asunto(s)
Transformación Celular Neoplásica/metabolismo , Neoplasias del Colon/etiología , Neoplasias del Colon/metabolismo , Proteínas de la Membrana/metabolismo , Células Madre Neoplásicas/metabolismo , Proteínas Plasmáticas de Unión al Retinol/metabolismo , Transducción de Señal , Animales , Línea Celular Tumoral , Autorrenovación de las Células/genética , Neoplasias del Colon/mortalidad , Neoplasias del Colon/patología , Dieta Alta en Grasa , Modelos Animales de Enfermedad , Expresión Génica , Xenoinjertos , Humanos , Estimación de Kaplan-Meier , Masculino , Proteínas de la Membrana/genética , Ratones , Células Madre Neoplásicas/patología , Pronóstico , Proteínas Plasmáticas de Unión al Retinol/genéticaRESUMEN
Vitamin A, retinol, circulates in blood bound to retinol binding protein (RBP). In some tissues, the retinol-RBP complex (holo-RBP) is recognized by a membrane receptor, termed STRA6, which mediates uptake of retinol into cells. Recent studies have revealed that, in addition to serving as a retinol transporter, STRA6 is a ligand-activated cell surface signaling receptor that, upon binding of holo-RBP activates JAK/STAT signaling, culminating in the induction of STAT target genes. It has further been shown that retinol transport and cell signaling by STRA6 are critically interdependent and that both are coupled to intracellular vitamin A metabolism. The molecular mechanism of action of STRA6 and its associated machinery is beginning to be revealed, but further work is needed to identify and characterize the complete range of genes and associated signaling cascades that are regulated by STRA6 in different tissues. An understanding of STRA6 is clinically relevant, as for example, it has been shown to be hyper- activated in obese animals, leading to insulin resistance. A potential role for STRA6 in other pathologies, including cancer, awaits further investigation.
Asunto(s)
Proteínas de la Membrana/fisiología , Vitamina A/metabolismo , Animales , Anoftalmos/genética , Anoftalmos/metabolismo , Transporte Biológico , Regulación de la Expresión Génica , Humanos , Resistencia a la Insulina , Quinasas Janus/fisiología , Enfermedades Pulmonares/genética , Enfermedades Pulmonares/metabolismo , Proteínas de la Membrana/deficiencia , Proteínas de la Membrana/genética , Ratones , Ratones Noqueados , Microftalmía/genética , Microftalmía/metabolismo , Obesidad/metabolismo , Especificidad de Órganos , Prealbúmina/fisiología , Proteínas Plasmáticas de Unión al Retinol/metabolismo , Factores de Transcripción STAT/fisiología , Transducción de Señal/fisiología , Transcripción GenéticaRESUMEN
It has long been established that the transcriptional activity of retinoic acid (RA) is mediated by members of the nuclear receptor family of ligand-activated transcription factors termed RA receptors (RARs). More recent observations have established that RA also activates an additional nuclear receptor, PPARß/δ. Partitioning RA between RARs and PPARß/δ is governed by different intracellular lipid-binding proteins: cellular RA binding protein 2 (CRABP2) delivers RA to nuclear RARs and a fatty acid binding protein (FABP5) delivers the hormone from the cytosol to nuclear PPARß/δ. Consequently, RA signals through RARs in CRABP2-expressing cells, but activates PPARß/δ in cells that express a high level of FABP5. RA elicits different and sometimes opposing responses in cells that express different FABP5/CRABP2 ratios because PPARß/δ and RARs regulate the expression of distinct sets of genes. An overview of the observations that led to the discovery of this non-classical activity of RA are presented here, along with a discussion of evidence demonstrating the involvement of the dual transcriptional activities of RA in regulating energy homeostasis, insulin responses, and adipocyte and neuron differentiation.
Asunto(s)
Regulación de la Expresión Génica/efectos de los fármacos , PPAR delta/fisiología , PPAR-beta/fisiología , Transcripción Genética/efectos de los fármacos , Tretinoina/farmacología , Adipogénesis/efectos de los fármacos , Adipogénesis/genética , Tejido Adiposo/metabolismo , Animales , Transporte Biológico , Proteínas de Unión a Ácidos Grasos/fisiología , Predicción , Regulación de la Expresión Génica/genética , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Regulación Neoplásica de la Expresión Génica/genética , Humanos , Modelos Moleculares , Proteínas de Neoplasias/fisiología , Neurogénesis/efectos de los fármacos , Neurogénesis/genética , Obesidad/metabolismo , PPAR delta/efectos de los fármacos , PPAR-beta/efectos de los fármacos , Conformación Proteica , Receptores de Ácido Retinoico/fisiologíaRESUMEN
The RNA-binding protein HuR binds to elements rich in adenylate and uridylate (AU-rich elements) in target mRNAs and stabilizes them against degradation. The complete spectrum of genes whose expression is regulated by HuR and are the basis for the broad range of cellular functions of the protein is incompletely understood. We show that HuR controls the expression of multiple components of the nuclear import machinery. Consequently, HuR is crucial for the nuclear import of cellular retinoic acid-binding protein 2 (CRABP2), which delivers RA to the nuclear retinoic acid receptor (RAR) and whose mobilization to the nucleus is mediated by a 'classical-like' nuclear localization signal (NLS). HuR is also required for heregulin-induced nuclear translocation of the NFκB subunit p65, which contains both classical and non-canonical NLSs. HuR thus regulates the transcriptional activities of both RAR and NFκB. The observations reveal that HuR plays a central role in regulating nuclear import of proteins.
Asunto(s)
Núcleo Celular/metabolismo , Proteína 1 Similar a ELAV/metabolismo , Transporte Activo de Núcleo Celular/efectos de los fármacos , Animales , Apoproteínas/metabolismo , Núcleo Celular/efectos de los fármacos , Retículo Endoplásmico/efectos de los fármacos , Retículo Endoplásmico/metabolismo , Células HEK293 , Humanos , Carioferinas/metabolismo , Células MCF-7 , Ratones , Proteínas Nucleares/genética , Proteínas Nucleares/metabolismo , Quinazolinas/farmacología , Estabilidad del ARN/genética , ARN Mensajero/genética , ARN Mensajero/metabolismo , Receptores de Ácido Retinoico/metabolismo , Tretinoina/farmacología , beta Carioferinas/metabolismoRESUMEN
Vitamin A, retinol, circulates in blood bound to retinol-binding protein (RBP4) which, in turn, associates with another serum protein, transthyretin (TTR), to form a ternary retinol-RBP4-TTR complex. At some tissues, retinol-bound (holo-) RBP4 is recognised by a receptor termed stimulated by retinoic acid 6 (STRA6) which transports retinol into cells. This mini-review summarises evidence demonstrating that, in addition to functioning as a retinol transporter, STRA6 is also a signalling receptor which is activated by holo-RBP4. The data show that STRA6-mediated retinol transport induces receptor phosphorylation, in turn activating a Janus kinases2/signal transducers and activators of transcription (STAT)3/5 cascade that culminates in induction of STAT target genes. STRA6-mediated retinol transport and cell signalling are inter-dependent, and both functions critically rely on intracellular retinol trafficking and metabolism. Hence, STRA6 couples 'sensing' of vitamin A homeostasis and metabolism to cell signalling, allowing it to control important biological functions. For example, by inducing the expression of the STAT target gene suppressor of cytokine signalling 3, STRA6 potently suppresses insulin responses. These observations provide a rationale for understanding the reports that elevation in serum levels of RBP4, often observed in obese mice and human subjects, causes insulin resistance. The observations indicate that the holo-RBP4 /STRA6 signalling cascade may comprise an important link through which obesity leads to insulin resistance and suggest that the pathway may be a novel target for treatment of metabolic diseases.
Asunto(s)
Insulina , Vitamina A/fisiología , Animales , Humanos , Resistencia a la Insulina , Proteínas de la Membrana/metabolismo , Ratones , Obesidad , Prealbúmina/metabolismo , Proteínas de Unión al Retinol/metabolismo , Proteínas Plasmáticas de Unión al Retinol/metabolismo , Factor de Transcripción STAT3/metabolismo , Factor de Transcripción STAT6/metabolismo , Transducción de Señal , Vitamina A/sangreRESUMEN
Long chain fatty acids (LCFA) serve as energy sources, components of cell membranes and precursors for signalling molecules. Here we show that these biological compounds also regulate gene expression and that they do so by controlling the transcriptional activities of the retinoic acid (RA)-activated nuclear receptors RAR and PPARß/δ. The data indicate that these activities of LCFA are mediated by FABP5, which delivers ligands from the cytosol to nuclear PPARß/δ. Both saturated and unsaturated LCFA (SLCFA, ULCFA) bind to FABP5, thereby displacing RA and diverting it to RAR. However, while SLCFA inhibit, ULCFA activate the FABP5/PPARß/δ pathway. We show further that, by concomitantly promoting the activation of RAR and inhibiting the activation of PPARß/δ, SLCFA suppress the oncogenic properties of FABP5-expressing carcinoma cells in cultured cells and in vivo. The observations suggest that compounds that inhibit FABP5 may constitute a new class of drugs for therapy of certain types of cancer.
Asunto(s)
Proteínas de Unión a Ácidos Grasos/metabolismo , Ácidos Grasos/metabolismo , Transducción de Señal , Tretinoina/metabolismo , Carcinogénesis/genética , Carcinogénesis/metabolismo , Línea Celular Tumoral , Regulación hacia Abajo , Proteínas de Unión a Ácidos Grasos/genética , Humanos , PPAR delta/genética , PPAR delta/metabolismo , PPAR-beta/genética , PPAR-beta/metabolismo , Receptores de Ácido Retinoico/genética , Receptores de Ácido Retinoico/metabolismoRESUMEN
The transcription factor Kruppel-like factor 2 (KLF2) displays anticarcinogenic activities but the mechanism that underlies this activity is unknown. We show here that KLF2 is markedly downregulated in human breast cancers and that its expression positively correlates with breast cancer patient survival. We show further that KLF2 suppresses tumor development by controlling the transcriptional activity of the vitamin A metabolite retinoic acid (RA). RA regulates gene transcription by activating two types of nuclear receptors: RA receptors (RARs), which inhibit tumor development, and peroxisome proliferator-activated receptor ß/δ (PPARß/δ), which promotes tumorigenesis. The partitioning of RA between these receptors is regulated by two carrier proteins: cellular retinoic acid-binding protein 2 (CRABP2), which delivers RA to RARs, and fatty acid-binding protein 5 (FABP5), which shuttles ligands to PPARß/δ. We show that KLF2 induces the expression of CRABP2 and RARγ and inhibits the expression FABP5 and PPARß/δ thereby shifting RA signaling from the pro-carcinogenic FABP5/PPARß/δ to the growth-suppressing CRABP2/RAR path. The data thus reveal that KLF2 suppresses tumor growth by controlling the transcriptional activities of RA.
Asunto(s)
Neoplasias de la Mama/metabolismo , Factores de Transcripción de Tipo Kruppel/metabolismo , Tretinoina/metabolismo , Animales , Neoplasias de la Mama/genética , Neoplasias de la Mama/patología , Línea Celular Tumoral , Proliferación Celular/fisiología , Transformación Celular Neoplásica , Regulación hacia Abajo , Proteínas de Unión a Ácidos Grasos/antagonistas & inhibidores , Femenino , Xenoinjertos , Humanos , Factores de Transcripción de Tipo Kruppel/genética , Células MCF-7 , Ratones , Ratones Desnudos , Receptores de Ácido Retinoico/biosíntesis , Receptores de Ácido Retinoico/genética , Transducción de Señal , Transcripción Genética , Receptor de Ácido Retinoico gammaRESUMEN
Retinol binding protein 4 (RBP4) is synthesized in the liver where it binds vitamin A, retinol, and transports it to tissues throughout the body. It has been shown in some studies that the level of circulating RBP4 increases with body mass, and the protein has been implicated as a mediator in the development of insulin resistance and the metabolic disease. Adipose tissue serves as another site of RBP4 synthesis, accounting for its designation as an adipokine. In addition to its function as a transport protein, RBP4 serves as a signaling molecule which, by binding to the membrane receptor STRA6, triggers downstream activation of pro-oncogenic pathways including JAK2/STAT3/5. Taken together, available information suggests the possibility that RBP4 may be a link between obesity and cancer.
Asunto(s)
Neoplasias/etiología , Neoplasias/metabolismo , Obesidad/etiología , Obesidad/metabolismo , Proteínas Plasmáticas de Unión al Retinol/metabolismo , Animales , Biomarcadores , Humanos , Insulina/metabolismo , Resistencia a la Insulina/genética , Metabolismo de los Lípidos , Proteínas de la Membrana/metabolismo , Síndrome Metabólico/epidemiología , Síndrome Metabólico/etiología , Síndrome Metabólico/metabolismo , Unión Proteica , Proteínas Plasmáticas de Unión al Retinol/genética , Transducción de SeñalRESUMEN
Vitamin A, retinol, circulates in blood bound to retinol-binding protein (RBP) which, in turn, associates with transthyretin (TTR) to form a retinol-RBP-TTR ternary complex. At some tissues, retinol-bound (holo-) RBP is recognized by a membrane protein termed STRA6, which transports retinol from extracellular RBP into cells and, concomitantly, activates a JAK2/STAT3/5 signaling cascade that culminates in induction of STAT target genes. STRA6-mediated retinol transport and cell signaling are critically inter-dependent, and they both require the presence of cellular retinol-binding protein 1 (CRBP1), an intracellular retinol acceptor, as well as a retinol-metabolizing enzyme such as lecithin:retinol acyltransferase (LRAT). STRA6 thus functions as a "cytokine signaling transporter" which couples vitamin A homeostasis and metabolism to cell signaling, thereby regulating gene transcription. Recent studies provided molecular level insights into the mode of action of this unique protein.
Asunto(s)
Proteínas de Unión al Retinol/metabolismo , Transducción de Señal , Vitamina A/metabolismo , Transporte Biológico , Humanos , Proteínas de la Membrana/metabolismo , Prealbúmina/metabolismoRESUMEN
Cellular retinoic acid-binding protein 2 (CRABP2) potently suppresses the growth of various carcinomas, but the mechanism(s) that underlies this activity remains incompletely understood. CRABP2 displays two distinct functions. The classical function of this protein is to directly deliver retinoic acid (RA) to RA receptor (RAR), a nuclear receptor activated by this hormone, in turn inducing the expression of multiple antiproliferative genes. The other function of the protein is exerted in the absence of RA and mediated by the RNA-binding and stabilizing protein HuR. CRABP2 directly binds to HuR, markedly strengthens its interactions with target mRNAs, and thus increases their stability and up-regulates their expression. Here we show that the anticarcinogenic activities of CRABP2 are mediated by both of its functions. Transcriptome analyses revealed that, in the absence of RA, a large cohort of transcripts is regulated in common by CRABP2 and HuR, and many of these are involved in regulation of oncogenic properties. Furthermore, both in cultured cells and in vivo, CRABP2 or a CRABP2 mutant defective in its ability to cooperate with RAR but competent in interactions with HuR suppressed carcinoma growth and did so in the absence of RA. Hence, transcript stabilization by the CRABP2-HuR complex significantly contributes to the ability of CRABP2 to inhibit tumorigenesis. Surprisingly, the observations also revealed that HuR regulates the expression of multiple genes involved in nuclear pore formation and is required for nuclear import of CRABP2 and for transcriptional activation by RAR. The data thus point at a novel function for this important protein.
Asunto(s)
Proteínas ELAV/genética , Regulación Neoplásica de la Expresión Génica , ARN Mensajero/genética , Receptores de Ácido Retinoico/genética , Activación Transcripcional , Transporte Activo de Núcleo Celular , Animales , Carcinogénesis/genética , Línea Celular Tumoral , Núcleo Celular/metabolismo , Proliferación Celular , Proteínas ELAV/metabolismo , Proteína 1 Similar a ELAV , Genes Reporteros , Humanos , Luciferasas/genética , Luciferasas/metabolismo , Ratones , Estabilidad del ARN , ARN Mensajero/metabolismo , Receptores de Ácido Retinoico/metabolismo , Transducción de Señal , Tretinoina/metabolismo , Tretinoina/farmacologíaRESUMEN
Vitamin A, retinol, circulates in blood bound to retinol-binding protein (RBP). At some tissues, RBP is recognized by STRA6, a plasma membrane protein that serves a dual role: it transports retinol from extracellular RBP into cells and it transduces a signaling cascade mediated by the Janus kinase JAK2 and the transcription factors STAT3 and STAT5. We show here that expression of RBP and STRA6 is markedly upregulated in human breast and colon tumors, that holo-RBP/STRA6 signaling promotes oncogenic properties, and that STRA6 expression is critical for tumor formation by colon carcinoma cells in vivo. The holo-RBP/STRA6 pathway also efficiently induces fibroblasts to undergo oncogenic transformation, rendering them highly tumorigenic. These data establish that holo-RBP and its receptor STRA6 are potent oncogenes and suggest that the pathway is a novel target for therapy of some human cancers.
Asunto(s)
Transformación Celular Neoplásica/genética , Neoplasias del Colon/genética , Proteínas de la Membrana/genética , Vitamina A/metabolismo , Neoplasias del Colon/patología , Regulación Neoplásica de la Expresión Génica , Células HCT116 , Células Hep G2 , Humanos , Janus Quinasa 2/genética , Proteínas de la Membrana/metabolismo , Proteínas de Unión al Retinol/biosíntesis , Proteínas de Unión al Retinol/genética , Transducción de Señal/genéticaRESUMEN
Fatty acid-binding proteins (FABPs) are a widely expressed group of calycins that play a well established role in solubilizing cellular fatty acids. Recent studies, however, have recast FABPs as active participants in vital lipid-signaling pathways. FABP5, like its family members, displays a promiscuous ligand binding profile, capable of interacting with numerous long chain fatty acids of varying degrees of saturation. Certain "activating" fatty acids induce the protein's cytoplasmic to nuclear translocation, stimulating PPARß/δ transactivation; however, the rules that govern this process remain unknown. Using a range of structural and biochemical techniques, we show that both linoleic and arachidonic acid elicit FABP5's translocation by permitting allosteric communication between the ligand-sensing ß2 loop and a tertiary nuclear localization signal within the α-helical cap of the protein. Furthermore, we show that more saturated, nonactivating fatty acids inhibit nuclear localization signal formation by destabilizing this activation loop, thus implicating FABP5 specifically in cis-bonded, polyunsaturated fatty acid signaling.
Asunto(s)
Proteínas de Unión a Ácidos Grasos/metabolismo , Ácidos Grasos/metabolismo , PPAR gamma/metabolismo , PPAR-beta/metabolismo , Animales , Ácido Araquidónico/química , Ácido Araquidónico/metabolismo , Ácido Araquidónico/farmacología , Sitios de Unión , Células COS , Núcleo Celular/efectos de los fármacos , Núcleo Celular/metabolismo , Chlorocebus aethiops , Citoplasma/efectos de los fármacos , Citoplasma/metabolismo , Proteínas de Unión a Ácidos Grasos/química , Proteínas de Unión a Ácidos Grasos/genética , Ácidos Grasos/química , Ácidos Grasos/farmacología , Humanos , Ligandos , Ácido Linoleico/química , Ácido Linoleico/metabolismo , Ácido Linoleico/farmacología , Células MCF-7 , Modelos Moleculares , Estructura Molecular , Mutación , Señales de Localización Nuclear/química , Señales de Localización Nuclear/metabolismo , PPAR gamma/genética , PPAR-beta/genética , Unión Proteica , Estructura Secundaria de Proteína , Estructura Terciaria de Proteína , Transporte de Proteínas/efectos de los fármacos , Activación Transcripcional/efectos de los fármacosRESUMEN
The RNA-binding protein HuR binds at 3' untranslated regions (UTRs) of target transcripts, thereby protecting them against degradation. We show that HuR directly interacts with cellular retinoic acid-binding protein 2 (CRABP2), a protein known to transport RA from the cytosol to the nuclear retinoic acid receptor (RAR). Association with CRABP2 dramatically increases the affinity of HuR toward target mRNAs and enhances the stability of such transcripts, including that of Apaf-1, the major protein in the apoptosome. We show further that its cooperation with HuR contributes to the ability of CRABP2 to suppress carcinoma cell proliferation. The data show that CRABP2 displays antioncogenic activities both by cooperating with RAR and by stabilizing antiproliferative HuR target transcripts. The observation that CRABP2 controls mRNA stabilization by HuR reveals that in parallel to participating in transcriptional regulation, the protein is closely involved in posttranscriptional regulation of gene expression.
Asunto(s)
Proteínas ELAV/metabolismo , Estabilidad del ARN , Receptores de Ácido Retinoico/metabolismo , Animales , Apoproteínas/metabolismo , Apoptosis/efectos de los fármacos , Apoptosis/genética , Factor Apoptótico 1 Activador de Proteasas/genética , Factor Apoptótico 1 Activador de Proteasas/metabolismo , Proliferación Celular/efectos de los fármacos , Células HEK293 , Humanos , Ratones , Unión Proteica/efectos de los fármacos , Unión Proteica/genética , Estabilidad del ARN/efectos de los fármacos , Estabilidad del ARN/genética , ARN Mensajero/genética , ARN Mensajero/metabolismo , Tretinoina/farmacología , Regulación hacia Arriba/efectos de los fármacos , Regulación hacia Arriba/genéticaRESUMEN
Endocannabinoids modulate multiple behaviors, including learning and memory. We show that the endocannabinoid anandamide (AEA) can alter neuronal cell function both through its established role in activation of the G-protein-coupled receptor CB1, and by serving as a precursor for a potent agonist of the nuclear receptor PPARß/δ, in turn up-regulating multiple cognition-associated genes. We show further that the fatty acid-binding protein FABP5 controls both of these functions in vivo. FABP5 both promotes the hydrolysis of AEA into arachidonic acid and thus reduces brain endocannabinoid levels, and directly shuttles arachidonic acid to the nucleus where it delivers it to PPARß/δ, enabling its activation. In accordance, ablation of FABP5 in mice results in excess accumulation of AEA, abolishes PPARß/δ activation in the brain, and markedly impairs hippocampus-based learning and memory. The data indicate that, by controlling anandamide disposition and activities, FABP5 plays a key role in regulating hippocampal cognitive function.
Asunto(s)
Ácidos Araquidónicos/metabolismo , Encéfalo/fisiología , Cognición/fisiología , Endocannabinoides/metabolismo , Proteínas de Unión a Ácidos Grasos/metabolismo , Proteínas de Neoplasias/metabolismo , PPAR delta/metabolismo , PPAR-beta/metabolismo , Alcamidas Poliinsaturadas/metabolismo , Transporte Activo de Núcleo Celular , Animales , Western Blotting , Encéfalo/metabolismo , Línea Celular Tumoral , Núcleo Celular/metabolismo , Proteínas de Unión a Ácidos Grasos/genética , Redes Reguladoras de Genes , Aprendizaje por Laberinto/fisiología , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Ratones Transgénicos , Microscopía Confocal , Proteínas de Neoplasias/genética , Análisis de Secuencia por Matrices de Oligonucleótidos , PPAR delta/agonistas , PPAR delta/genética , PPAR-beta/agonistas , PPAR-beta/genética , Unión Proteica , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Tiazoles/farmacología , Transcriptoma/efectos de los fármacosRESUMEN
Vitamin A, retinol, circulates in blood bound to retinol-binding protein (RBP). At some tissues, holo-RBP is recognized by a plasma membrane receptor termed STRA6, which serves a dual role: it mediates transport of retinol from RBP into cells, and it functions as a cytokine receptor that, on binding holo-RBP, activates JAK2/STAT5 signaling. As STAT target genes include SOCS3, an inhibitor of insulin receptor, holo-RBP suppresses insulin responses in STRA6-expressing cells. We have shown previously that the two functions of STRA6 are interdependent. These observations suggest factors that regulate STRA6-mediated retinol transport may also control STRA6-mediated cell signaling. One such factor is retinol metabolism, which enables cellular uptake of retinol by maintaining an inward-directed concentration gradient. We show here that lecithin:retinol acyl transferase (LRAT), which catalyzes esterification of retinol to its storage species retinyl esters, is necessary for activation of the STRA6/JAK2/STAT5 cascade by holo-RBP. In accordance, LRAT-null mice are protected from holo-RBP-induced suppression of insulin responses. Hence, STRA6 signaling, which requires STRA6-mediated retinol transport, is supported by LRAT-catalyzed retinol metabolism. The observations demonstrate that STRA6 regulates key cellular processes by coupling circulating holo-RBP levels and intracellular retinol metabolism to cell signaling.
Asunto(s)
Aciltransferasas/metabolismo , Proteínas de la Membrana/metabolismo , Proteínas de Unión al Retinol/metabolismo , Aciltransferasas/genética , Animales , Ingestión de Alimentos/fisiología , Prueba de Tolerancia a la Glucosa , Células Hep G2 , Humanos , Proteínas de la Membrana/genética , Ratones , Células 3T3 NIH , Reacción en Cadena en Tiempo Real de la Polimerasa , Proteínas de Unión al Retinol/genética , Proteína 3 Supresora de la Señalización de Citocinas , Proteínas Supresoras de la Señalización de Citocinas/genética , Proteínas Supresoras de la Señalización de Citocinas/metabolismo , Vitamina A/metabolismoRESUMEN
The vitamin A metabolite retinoic acid (RA) regulates gene transcription by activating the nuclear receptors RAR and PPARß/δ and their cognate lipid binding proteins CRABP-II, which delivers RA to RAR, and FABP5, which shuttles the hormone to PPARß/δ. In preadipocytes, RA signals predominantly through CRABP-II and the RAR isotype RARγ to induce the expression of hallmark markers of preadipocytes Pref-1, Sox9, and KLF2. RA thus maintains the preadipocyte phenotype and inhibits adipogenesis. In mature adipocytes, RA activates both of its receptors to upregulate expression of genes that enhance lipid oxidation, energy dissipation, and insulin responses. Consequently, RA potently protects mice from diet-induced obesity and insulin resistance by two distinct mechanisms: by counteracting adipogenesis, thereby moderating the formation of new fat cells, and by promoting energy expenditure, thereby preventing adipocyte hypertrophy.
RESUMEN
The plasma membrane protein STRA6 is thought to mediate uptake of retinol from its blood carrier retinol-binding protein (RBP) into cells and to function as a surface receptor that, upon binding of holo-RBP, activates a JAK/STAT cascade. It was suggested that STRA6 signaling underlies insulin resistance induced by elevated serum levels of RBP in obese animals. To investigate these activities in vivo, we generated and analyzed Stra6-null mice. We show that the contribution of STRA6 to retinol uptake by tissues in vivo is small and that, with the exception of the eye, ablation of Stra6 has only a modest effect on retinoid homeostasis and does not impair physiological functions that critically depend on retinoic acid in the embryo or in the adult. However, ablation of Stra6 effectively protects mice from RBP-induced suppression of insulin signaling. Thus one biological function of STRA6 in tissues other than the eye appears to be the coupling of circulating holo-RBP levels to cell signaling, in turn regulating key processes such as insulin response.